| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.0009 |